Association Between Sumatriptan Treatment During a Migraine Attack and Central 5-HT1B Receptor Binding | Zendy

Marie Deen | Zendy; Anders Hougaard | Zendy; Hanne D. Hansen | Zendy; Martin Schain | Zendy; Agnete Dyssegaard | Zendy; Gitte M. Knudsen | Zendy; Messoud Ashina | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Association Between Sumatriptan Treatment During a Migraine Attack and Central 5-HT_1B Receptor Binding

Author(s) -

Marie Deen,

Anders Hougaard,

Hanne D. Hansen,

Martin Schain,

Agnete Dyssegaard,

Gitte M. Knudsen,

Messoud Ashina

Publication year - 2019

Publication title -

jama neurology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.298

H-Index - 231

eISSN - 2168-6157

pISSN - 2168-6149

DOI - 10.1001/jamaneurol.2019.0755

Subject(s) - sumatriptan , migraine , triptans , migraine with aura , aura , migraine treatment , medicine , anesthesia , 5 ht receptor , cortical spreading depression , receptor , serotonin , agonist

Triptans, the most efficient acute treatment for migraine attacks, are 5-HT1B/1D receptor agonists, but their precise mechanism of action is not completely understood. The extent to which triptans enter the central nervous system and bind to 5-HT1B receptors in the brain is unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research